Drawing for SAMJIN SAMJIN PHARM.

USPTO serial 79402877

SAMJIN SAMJIN PHARM.

Reviewed by CopyMark Law Group

Reg. 7839060Status 700Registered
Filing date
Status date
Registration date
Jun 24, 2025
Examiner
KOPENSKI, CLAUDIA ANN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SAMJIN SAMJIN PHARM.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jae Youn Kim

Jae Youn Kim NKL Law3251 Blenheim BlvdSuite 500Fairfax, VA 22030

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for health care for treating of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorder; vitamin and mineral dietary supplements; vitamin supplements; crude medicines for relieving anxiety, tension, dyspepsia, obesity, pain, hypertension, insomnia, diabetes; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; pharmaceutical drugs in the nature of antiviral pharmaceuticals, antibacterial pharmaceuticals, psychiatric pharmaceuticals, oncological pharmaceuticals, surgical pharmaceuticals; analgesics; probiotic supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 25, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 25, 2026FIMPFINAL DISPOSITION PROCESSED—
Jan 25, 2026CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Sep 24, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 1, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 24, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 24, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 6, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 30, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 30, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 10, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 10, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 3, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 2, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2024DOCKASSIGNED TO EXAMINER—
Aug 22, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 22, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 22, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance